Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Juni Chakraborty
WITHDRAWN: Curcumin Shifts RAS-induced Pro-Proliferative MEK/ERK-signaling Toward Pro-Apoptotic P38MAPK/JNK1-signaling, Triggering P53 Activation and Apoptosis
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Curcumin Enhances the Efficacy of Chemotherapy by Tailoring P65NFκB-P300 Cross-Talk in Favor of P53-P300 in Breast Cancer
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Related publications
EGF Receptor and PKCδ Kinase Activate DNA Damage-Induced Pro-Survival and Pro-Apoptotic Signaling via Biphasic Activation of ERK and MSK1 Kinases
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Molecular Signaling in Multiple Myeloma: Association of RAS/RAF Mutations and MEK/ERK Pathway Activation
Oncogenesis
Cancer Research
Molecular Biology
Pro‑apoptotic and Anti‑proliferative Effects of Mitofusin‑2 via PI3K/Akt Signaling in Breast Cancer Cells
Oncology Letters
Cancer Research
Oncology
Genotoxic Stress/P53-Induced DNAJB9 Inhibits the Pro-Apoptotic Function of P53
Cell Death and Differentiation
Cell Biology
Molecular Biology
NF2 Signaling Pathway Plays a Pro-Apoptotic Role in Β-Adrenergic Receptor Stimulated Cardiac Myocyte Apoptosis
PLoS ONE
Multidisciplinary
Divergence of Bacterial Lipopolysaccharide Pro-Apoptotic Signaling Downstream of IRAK-1
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Ras/Mek Signaling Suppresses Myc-Dependent Apoptosis in Cells Transformed by C-Myc and Activated Ras
Oncogene
Cancer Research
Genetics
Molecular Biology
P1.03-21 Huaier Aqueous Extract Induces Lung Adenocarcinoma Cell Apoptosis Through Excessive Activation of MEK/ERK Signaling Pathway
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Tumor P38MAPK Signaling Enhances Breast Carcinoma Vascularization and Growth by Promoting Expression and Deposition of Pro-Tumorigenic Factors
Oncotarget
Oncology